Poltreg S.A. (WSE:PTG)
Poland · Delayed Price · Currency is PLN 23.40
+0.40 (1.74%)
Jul 24, 2026, 5:00 PM CET
Poltreg Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
37
Market Cap
138.45M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 350.00K | -1.05M | -74.98% |
| Dec 31, 2023 | 1.40M | 400.00K | 40.04% |
| Dec 31, 2022 | 999.00K | -100.00K | -9.10% |
| Dec 31, 2021 | 1.10M | 399.00K | 57.00% |
| Dec 31, 2020 | 700.00K | 200.00K | 40.00% |
| Dec 31, 2019 | 500.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 266.02M |
| Ryvu Therapeutics | 88.38M |
| Synthaverse | 42.19M |
| Mabion | 17.61M |
| Molecure | 6.52M |
| Urteste | 2.50M |
| Captor Therapeutics Spolka Akcyjna | 2.38M |
| Pharmena | 1.61M |
Poltreg News
- 2 months ago - Poltreg Quarterly report: Q1 2026 - Filings
- 3 months ago - Poltreg Annual report: Q4 2025 - Filings
- 8 months ago - Poltreg Quarterly report: Q3 2025 - Filings
- 11 months ago - Poltreg Quarterly report: Q2 2025 - Filings